Targeting TP53 to augment therapeutic response in head and neck cancer

Agriculture & Biology

• head and neck neoplasms 100%
• therapeutics 43%
• mutants 32%
• oropharyngeal neoplasms 24%
• drug therapy 22%
• apoptosis 20%
• metformin 17%
• neoplasms 17%
• cell senescence 16%
• Papillomaviridae 15%
• radiotherapy 15%
• mutation 15%
• radiation resistance 15%
• cell cycle checkpoints 14%
• Adenoviridae 12%
• gene transfer 11%
• clinical trials 11%
• nanoparticles 10%
• reactive oxygen species 9%
• metabolism 6%
• proteins 3%
• cells 3%

Medicine & Life Sciences

• Head and Neck Neoplasms 55%
• Oropharyngeal Neoplasms 18%
• Apoptosis 16%
• Whole Exome Sequencing 16%
• Mutation 15%
• Survival 15%
• Cellular Senescence 15%
• Metformin 14%
• Mutant Proteins 14%
• Combination Drug Therapy 14%
• Adenoviridae 13%
• Cell Cycle Checkpoints 13%
• Genetic Therapy 12%
• Nanoparticles 12%
• Reactive Oxygen Species 11%
• Radiation 10%
• Radiotherapy 9%
• Therapeutics 9%
• Clinical Trials 9%
• Neoplasms 8%
• Drug Therapy 8%
• In Vitro Techniques 6%

Chemistry

• Mutation 47%
• Metformin 39%
• Reactive Oxygen Metabolite 26%
• Marker 24%
• Metabolic 22%
• Pharmacological Metabolism 21%
• Resistance 17%
• Nanoparticle 13%
• Protein 11%
• Molecule 9%